BLT 0.00% 2.6¢ benitec biopharma limited

Well considering the whole company is only worth 35 million...

  1. 587 Posts.
    Well considering the whole company is only worth 35 million dollars to get enough money to complete just the head and neck cancer phase 2/3 trial will be worth more than the entire company. Seems a bit absurd. So we need to dilute over 100% just to maybe finish one trial. This just demonstrates how absurdly undervalued we are at this point in my opinion.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.